Pituitary apoplexy during therapy with cabergoline in an adolescent male with prolactin-secreting macroadenoma

Pituitary

Volumn 7, Issue 2, 2004, Pages 83-87

  Knoepfelmacher, Mirta ^a,b   Gomes, Miriam C ^a   Melo, Maria E ^a   Mendonca, Berenice B ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b NONE   (Brazil)

Author keywords

Cabergoline; Macroprolactinoma; Pituitary apoplexy; Puberty arrest

Indexed keywords

BROMOCRIPTINE; CABERGOLINE; CORTISONE ACETATE; CREATININE; DEXAMETHASONE; GLUCOSE; GONADOTROPIN; GROWTH HORMONE; HYDROCORTISONE; LEVOTHYROXINE; LUTEINIZING HORMONE; POTASSIUM; PROLACTIN; SODIUM; THYROTROPIN; UREA;

ADOLESCENT; ARTICLE; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DRUG HYPERSENSITIVITY; GROWTH DISORDER; GROWTH HORMONE DEFICIENCY; HORMONE SUBSTITUTION; HUMAN; HYPOPHYSIS APOPLEXY; HYPOPITUITARISM; HYPOTHYROIDISM; MALE; MENTAL DEFICIENCY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; PROLACTINOMA; PUBERTY; SEXUAL DEVELOPMENT;

ADENOMA; ADOLESCENT; ANTINEOPLASTIC AGENTS; CEREBROVASCULAR ACCIDENT; ERGOLINES; HUMANS; HYPOPITUITARISM; MAGNETIC RESONANCE IMAGING; MALE; PITUITARY DISEASES; PITUITARY NEOPLASMS; PROLACTIN; PROLACTINOMA;

EID: 14944386037     PISSN: 1386341X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11102-005-5349-x     Document Type: Article

References (28)

1. Rolih CA, Ober KP. Pituitary apoplexy. Endocrinology and Metabolism Clin N Am 1993;22:291-302.
2. Randeva HS, Schoebel J, Byrne J, Esiri M, Adams CBT, Wass JAH. Classical pituitary apoplexy: Clinical features, management and outcome. Clin Endocrinol 1999;51:181-188.
3. Biousse V, Newman NJ, Oyesiku NM. Precipitating factors in pituitary apoplexy. J Neurol Neuros and Psych 2001;71:542-545.
4. Yamajix J, Ishibashi M, Kosaka K, Hori T, Manaka S. Pituitary apoplexy in acromegaly during bromocriptine therapy. Acta Endocrinol (Copenh.) 1981;98(2):171-177.
5. Shirataki K, Chihara K, Shibata Y, Tamaki N, Matsumoto S, Fujita T. Pituitary apoplexy manifested during a bromocriptine test in a patient with growth hormone and prolactin producing pituitary adenoma. Neurosurgery 1988;23:395-398.
6. Pinto G, Zerah M, Trivin C, Brauner R. Pituitary apoplexy in an adolescent with prolactin-secreting adenoma. Hormone Research 1998;50:38-41.
7. Vance ML, Evans W, Thorner M. Bromocriptine Ann Intern Med 1984;100:78-91.
8. Liuzzi A, Dallabonzana D, Oppizzi G, Verde GG, Cozzi R, Chiodini P, Luccarelli G. Low dose of dopamine agonists in the long-term treatment of macroprolactinomas. N Engl J Med 1985;313:656-659.
9. Molitch ME, Elton RL, Blackwell RE, Caldwell B, Chang RJ, Jaffe R, Joplin G, Robbins RJ, Tyson J, Thorner MO. Bromocriptine as primary therapy for prolactin-secreting macroprolactinomas: Result of a prospective multicenter study. J Clin Endocrinol Metab 1985;60:698-705.
10. Biller BMK, Molitch ME, Vance ML,Cannistraro KB, Davis KR, Simons JA, Schoenfelder JR, Kklibanski A. Treatment of prolactin-secreting macroadenomas with once-weekly dopamine agonist cabergoline. J Clin Endocrinol Metab 1996;81:2338-2343.
11. Ferrari CI, Abs R, Bevan JS, Brabant G,Ciccarelli E, Motta T, Mucci M, Muratori M, Musatti L, Verbessem G, Scanlon MF. Treatment of macroprolactinomas with cabergoline: A study of 85 patients. Clin Endocrinol (Oxf.) 1997;46:409-415.
12. Colao A, Di Sarno A, Landi ML, Crillo S, Sarnacchiaro F, Facciolli G, Annunziato L, Lombardi G. Long-term and low-dose treatment with cabergoline induces macroprolactinoma shrinkage. J Clin Endocrinol Metab 1997;82:3574-3579.
13. Verhelst J, Abs R, Maiter D, Van Den Bruel A, Vandeweghe M, Velkeniers B, Mockel J, Lamberigts, Perossians P, Coremans P, Mahler C, Stevenaert A, Verlooy J, Raftopoulos C, Beckers A. Cabergoline in the tretment of hyperprolactinemia: A study in 455 patients. J Clin Endocrinol Metab 1999;84:2518-2522.
14. Colao A, Loche S, Cappa M, Di Sarno A, Landi ML, Sarnacchiao F, Faccioli G, Lombardi, G. Prolactinomas in children and adolescents. Clinical presentation and long-term follow-up. J Clin Endocrinol Metab 1998;83:2777-2780.
15. Partington MD, Davis DH, Laws ER Jr, Scheithauer BW. Pituitary adenomas in childhood and adolescence: Results of transsphenoidal surgery. J Neuros 1994;80:209-216.
16. Mindermann T, Wilson CB. Pituitary adenomas in childhood and adolescence. Journal of Pediatric Endocrinology and Metaboslism 1995;8:79-83.
17. Knwar S, Wilson CB. Pediatric pituitary adenomas. J Clin Endocrinol Metab 1999;84:4385-4389.
18. Calle-Rodrigue RD, Gianni C, Scherthauer BW, Lloyd RV, Wollan PC, Kovacs KT, Stefaneanu L, Ebright AB, Abboud CF, Davis DH. Prolactinomas in male and female patients: A comparative clinical pathologic study. Mayo Clinic Proc 1998;73:1046-1052.
19. Delgrange E, Maiter D, Donckier J, Tourniare J. Influence of age on the clinical presentations of prolactinomas in male. Min Endocrinol 1998;23(1):7-16.
20. Tyson D, Reggiardo D, David R. Prolactin-secreting macroadenomas in adolescents. Response to bromocriptine therapy. Am J Dis Child 1993;147:1057-1061.
21. Delgrange E, Trouillas J, Maiter D, Donckier J, Tourniaire J. Sex-related difference in the growth of prolactinomas: A clinical and proliferation marker study. J Clin Endocrinol Metab 1997;82:2102-2107.
22. Albuquerque PC, Hinton DR, Weiss MH. Excessively high prolactin level in a patient with a nonprolactin-secreting adenoma: Case report. J Neuros 1998;89:1043-1046.
23. Wakai S, Fukushima T, Teramoto A, Sano K. Pituitary apoplexy: Its incidence and clinical significance. J Neuros 1981;55:187-193.
24. Mohr G, Hardy J. Haemorrhage, necrosis and apoplexy in pituitary adenomas. Surg Neurol 1982;18:181-189.
25. Miranda M, Barros L, Knoepfelmacher M, Augusto E, Jacomosi A, Cukiert A, Salgado LR, Goldman J, Liberman B. Pituitary apoplexy followed by endocrine remission. Report of two cases. Arqu Neuro-Psiq 1998;56(3):449-452.
26. Knoepfelmacher M, Ursich M, Barros LM, Duarte A, Salgado LR, Pimentel-Filho FB, Liberman B. Insulin resistance associated to high levels of TNF during pituitary apoplexy induced by a pituitary stimulating test in an acromegalic patient. The Endocrinologist 2001;11:425-428.
27. Cardoso ER, Peterson EW. Pituitary apoplexy: A review. Neurosurgery 1984;14:363-373.
28. Colao A, Di Sarno A, Landi ML, Scavuzzo F, Cappabianca P, Pivonello R, Volpe R, Di Salle F, Cirillo S, Annunziato L, Lombardi G. Macroprolactinoma Shrinkage during cabergoline treatment is greater in naive patients than in patients pretreated with other dopamine agonists: A prospective study in 110 patients. J Clin Endocrinol Metab 2000;87:2247-2252.